Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Commentary

COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients

Marc C Hochberg

Arthritis Res Ther 2003, 5:28-31  doi:10.1186/ar617

Accesses  

  • Last 30 days: 23 accesses
  • Last 365 days: 758 accesses
  • All time: 4500 accesses